– USA, NJ – Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Dr. Steve Mayo, professor, California Institute of Technology, to its Board of Directors, effective March 15, 2021, bringing the board to 14 members.
“We are pleased to welcome Dr. Mayo to the Merck Board. He brings extensive scientific expertise, and we look forward to his contributions and insights,” said Chairman and CEO, Kenneth Frazier.
About Dr. Steve Mayo
Dr. Mayo is the Bren Professor of Biology and Chemistry at the California Institute of Technology, where he has held several other roles, including Chair of the Division of Biology & Biological Engineering and Vice Provost. Elected to the National Academy of Sciences in 2004 for his pioneering contributions in the field of protein design, Dr. Mayo has also served as a presidential appointee on the National Science Foundation’s National Science Board and as an elected board member for the American Association for the Advancement of Science.
Dr. Mayo earned his bachelor’s degree in chemistry from Pennsylvania State University and a Ph.D. in chemistry from the California Institute of Technology.
About Merck
For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs, and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.
For more information: https://www.merck.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.